232 related articles for article (PubMed ID: 15653447)
21. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
[TBL] [Abstract][Full Text] [Related]
22. The intra-individual stability of GH biomarkers IGF-I and P-III-NP in relation to GHRH administration, menstrual cycle, and hematological parameters.
Ericsson M; Bhuiyan H; Yousif B; Lehtihet M; Ekström L
Drug Test Anal; 2020 Nov; 12(11-12):1620-1628. PubMed ID: 33125822
[TBL] [Abstract][Full Text] [Related]
23. Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.
Cowan DA; Moncrieffe DA
Drug Test Anal; 2022 May; 14(5):808-819. PubMed ID: 34418311
[TBL] [Abstract][Full Text] [Related]
24. Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.
Sartorio A; Agosti F; Marazzi N; Maffiuletti NA; Cella SG; Rigamonti AE; Guidetti L; Di Luigi L; Muller EE
Clin Endocrinol (Oxf); 2004 Oct; 61(4):487-93. PubMed ID: 15473882
[TBL] [Abstract][Full Text] [Related]
25. Application of the Athlete Biological Passport Approach to the Detection of Growth Hormone Doping.
Equey T; Pastor A; de la Torre Fornell R; Thomas A; Giraud S; Thevis M; Kuuranne T; Baume N; Barroso O; Aikin R
J Clin Endocrinol Metab; 2022 Feb; 107(3):649-659. PubMed ID: 34726230
[TBL] [Abstract][Full Text] [Related]
26. Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays.
Chanson P; Arnoux A; Mavromati M; Brailly-Tabard S; Massart C; Young J; Piketty ML; Souberbielle JC;
J Clin Endocrinol Metab; 2016 Sep; 101(9):3450-8. PubMed ID: 27167056
[TBL] [Abstract][Full Text] [Related]
27. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes.
Erotokritou-Mulligan I; Bassett EE; Bartlett C; Cowan D; McHugh C; Seah R; Curtis B; Wells V; Harrison K; Sönksen PH; Holt RI;
J Clin Endocrinol Metab; 2008 Jul; 93(7):2760-3. PubMed ID: 18413420
[TBL] [Abstract][Full Text] [Related]
28. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
[TBL] [Abstract][Full Text] [Related]
29. Anti-doping analytes in serum: A comparison of SST and SST-II Advance blood collection tubes.
Miller GD; Cox HD; Nair V; Eichner D
Drug Test Anal; 2019 Jul; 11(7):931-936. PubMed ID: 30901507
[TBL] [Abstract][Full Text] [Related]
30. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects.
Okano M; Nishitani Y; Sato M; Ikekita A; Kageyama S
Drug Test Anal; 2010; 2(11-12):548-56. PubMed ID: 21249726
[TBL] [Abstract][Full Text] [Related]
31. Potential parameters for the detection of hGH doping.
Kniess A; Ziegler E; Kratzsch J; Thieme D; Müller RK
Anal Bioanal Chem; 2003 Jul; 376(5):696-700. PubMed ID: 12750868
[TBL] [Abstract][Full Text] [Related]
32. A follow-up of GH-dependent biomarkers during a 6-month period of the sporting season of male and female athletes.
Sartorio A; Jubeau M; Agosti F; Marazzi N; Rigamonti A; Müller EE; Maffiuletti NA
J Endocrinol Invest; 2006 Mar; 29(3):237-43. PubMed ID: 16682837
[TBL] [Abstract][Full Text] [Related]
33. Immunoradiometric assay measurements of insulin-like growth factor-I (IGF-I): comparison with radioimmunoassays using native or des (1-3) IGF-I as radioligands.
Homayoun P; Daher R; Van Lente F; Faiman C; Gupta MK
J Clin Lab Anal; 1996; 10(6):446-50. PubMed ID: 8951618
[TBL] [Abstract][Full Text] [Related]
34. Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse.
Erotokritou-Mulligan I; Bassett EE; Cowan DA; Bartlett C; McHugh C; Sönksen PH; Holt RI;
Clin Endocrinol (Oxf); 2009 Jan; 70(1):161-8. PubMed ID: 18616716
[TBL] [Abstract][Full Text] [Related]
35. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
Young RR; Bielak JS; Horvitz SL
Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
37. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
Lassarre C; Binoux M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
[TBL] [Abstract][Full Text] [Related]
38. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport.
Cox HD; Rampton J; Eichner D
Anal Bioanal Chem; 2013 Feb; 405(6):1949-58. PubMed ID: 23263515
[TBL] [Abstract][Full Text] [Related]
39. Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA Centaur platform. Validation, reference interval and comparison to UniQ RIA.
Knudsen CS; Heickendorff L; Nexo E
Clin Chem Lab Med; 2014 Feb; 52(2):237-41. PubMed ID: 24114914
[TBL] [Abstract][Full Text] [Related]
40. Moving one step closer to catching the GH cheats: The GH-2004 experience.
Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
